FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hans Klingemann

Research Profile

Anatomy

Procedures

Disorders

Chemicals & Drugs

Physiology

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Hans Klingemann; Raymond L Comenzo; Elliott Cutler; Marvin Duque; Carrie Grodman; Diane Kadidlo; Tarun Kewalramani; Andreas K Klein; Kenneth B Miller; Kellie A Sprague; Richard A Van Etten; Neng Yu; David H McKenna
Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions.
Scott A Koepsell; Jeffrey McCullough; Susan Fautsch; Diane Kadidlo; Hans Klingemann; Jeffrey S Miller; John E Wagner; David H McKenna
Successful "in-flight" activation of natural killer cells during long-distance shipping.
Laurent Boissel; Monica Betancur; Weiquan Lu; Teresa Marino; Richard A Van Etten; Winfried S Wels; Hans Klingemann
Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigens.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hans Klingemann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Hans Klingemann; Raymond L Comenzo; Elliott Cutler; Marvin Duque; Carrie Grodman; Diane Kadidlo; Tarun Kewalramani; Andreas K Klein; Kenneth B Miller; Kellie A Sprague; Richard A Van Etten; Neng Yu; David H McKenna
Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions.
Transfusion 2013;53(2):412-8; quiz 411.
2013: Scott A Koepsell; Jeffrey McCullough; Susan Fautsch; Diane Kadidlo; Hans Klingemann; Jeffrey S Miller; John E Wagner; David H McKenna
Successful "in-flight" activation of natural killer cells during long-distance shipping.
Transfusion 2013;53(2):398-403.
2012: Laurent Boissel; Monica Betancur; Weiquan Lu; Teresa Marino; Richard A Van Etten; Winfried S Wels; Hans Klingemann
Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigens.
Leukemia & lymphoma 2012;53(5):958-65.
2009: Laurent Boissel; Monica Betancur; Winfried S Wels; Hande Tuncer; Hans Klingemann
Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells.
Leukemia research 2009;33(9):1255-9.
2009: James Weitzman; Monica Betancur; Laurent Boissel; Arthur P Rabinowitz; Andreas Klein; Hans Klingemann
Variable contribution of monoclonal antibodies to ADCC in patients with chronic lymphocytic leukemia.
Leukemia & lymphoma 2009;50(8):1361-8.
2008: Laurent Boissel; Hande H Tuncer; Monica Betancur; Adam Wolfberg; Hans Klingemann
Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(9):1031-8.
2008: Hans Klingemann; L Boissel
Targeted cellular therapy with natural killer cells.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2008;40(2):122-5.
2007: Robb Friedman; Monica Betancur; Laurent Boissel; Hande Tuncer; Curtis L Cetrulo; Hans Klingemann
Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(12):1477-86.
2006: Hans Klingemann
Discarded stem cells with a future?
Expert opinion on biological therapy 2006;6(12):1251-4.
2004: Nicolaus Kröger; Jose A Perez-Simon; Han Myint; Hans Klingemann; Avichai Shimoni; Arnon Nagler; Rodrigo Martino; Adrian Alegre; Jose F Tomas; Rainer Schwerdtfeger; Michael Kiehl; Axel A Fauser; Herbert G Sayer; Angel Leon; Jörg Beyer; Tatjana Zabelina; Francis Ayuk; Jesús F San Miguel; Ronald Brand; Axel R Zander
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(10):698-708.
2004: Nicolaus Kröger; Georgia Schilling; Hermann Einsele; Peter Liebisch; Avichai Shimoni; Arnon Nagler; Jose A Perez-Simon; Jesús F San Miguel; Michael Kiehl; Axel A Fauser; Rainer Schwerdtfeger; Hannes Wandt; Herbert G Sayer; Han Myint; Hans Klingemann; Tatjana Zabelina; Judith Dierlamm; Axel Hinke; Axel R Zander
Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation.
Blood 2004;103(11):4056-61.